| Literature DB >> 27839517 |
Leda Nobile1, Fabio S Taccone1, Tamas Szakmany2,3, Yasser Sakr4, Stephan M Jakob5, Tommaso Pellis6, Massimo Antonelli7, Marc Leone8, Xavier Wittebole9, Peter Pickkers10, Jean-Louis Vincent11.
Abstract
BACKGROUND: We used data from a large international database to assess the incidence and impact of extracerebral organ dysfunction on prognosis of patients admitted after cardiac arrest (CA).Entities:
Mesh:
Year: 2016 PMID: 27839517 PMCID: PMC5108077 DOI: 10.1186/s13054-016-1528-6
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Characteristics of the study population, according to ICU survival and neurological outcome at hospital discharge
| All patients ( | Survivors ( | Non-survivors ( | Favorable neurological outcome ( | Unfavorable neurological outcome ( | |
|---|---|---|---|---|---|
| Age, years | 66 (52–77) | 65 (52–75) | 68 (52–78) | 67 (53–75) | 66 (52–77) |
| Male, | 282 (61) | 149 (61) | 126 (61) | 60 (62) | 222 (60) |
| Weight, kg | 75 (65–87) | 75 (66–90) | 71 (61–83) | 75 (65–90) | 74 (65–85) |
| OHCA, | 250 (53) | 120 (49) | 124 (59) | 34 (35) | 216 (58) |
| IHCA, | 219 (47) | 127 (51) | 86 (41) | 63 (65) | 156 (42) |
| No co-morbidities, | 209 (44) | 101 (41) | 108 (51) | 49 (51) | 163 (44) |
| COPD/asthma, | 65 (14) | 39 (16) | 26 (12) | 17 (17) | 51 (14) |
| Heart failure, | 72 (15) | 30 (12) | 42 (20) | 10 (10) | 62 (17) |
| Diabetes, | 45 (10) | 20 (8) | 25 (12) | 12 (12) | 33 (9) |
| Cancer, | 38 (8) | 18 (7) | 20 (10) | 10 (10) | 28 (8) |
| Chemotherapy, | 9 (2) | 4 (2) | 5 (2) | 1 (1) | 8 (2) |
| Liver cirrhosis, | 14 (3) | 1 (1) | 13 (6) | 1 (1) | 13 (3) |
| Chronic renal failure, | 50 (11) | 21 (9) | 29 (14) | 10 (10) | 40 (11) |
| HIV, | 1 (0) | – | 1 (1) | – | 1 (1) |
| Corticosteroids, | 14 (3) | 6 (2) | 8 (4) | 1 (1) | 13 (3) |
| Medical admission, | 373 (83) | 189 (91) | 184 (89) | 70 (74) | 303 (84) |
| SAPS II score on admission | 60 (46–75) | 53 (39–64) | 71 (57–81)* | 38 (29–49) | 65(54–79)* |
| SOFA score on admission | 10 (7–13) | 8 (6–11) | 12 (9–14)* | 6 (3–8) | 11(8–13)* |
| Infections | |||||
| Infection on admission, | 112 (24) | 60 (24) | 52 (25) | 20 (21) | 92 (25) |
| Infection any time, | 200 (43) | 120 (49) | 80 (38) | 41 (41) | 159 (43) |
| Septic shock on admission, | 75 (16) | 40 (16) | 35 (17) | 11 (11) | 64 (17) |
| Septic shock any time, | 133 (28) | 74 (30) | 59 (28) | 20 (21) | 113 (30) |
| Vasopressors on admission, | 262 (57) | 124 (50) | 138 (66)* | 42 (43) | 220 (62)* |
| Mechanical ventilation on admission, | 408 (87) | 205 (83) | 203 (97) | 67 (69) | 341 (92)* |
| Mechanical ventilation any time, | 425 (91) | 211 (85) | 204 (97) | 71 (73) | 354 (95)* |
| Hemodialysis/CRRT on admission, | 38 (8) | 19 (8) | 19 (9) | 4 (4) | 34 (9) |
| Hemodialysis/CRRT any time, | 103 (23) | 59 (24) | 44 (21) | 17 (17) | 86 (23) |
| MAP maximum on first day, mmHg | 99 (87–112) | 100 (89–113) | 97 (85–111) | 100 (88–113) | 98 (87–112) |
| MAP minimum on first day, mmHg | 61 (50–70) | 63 (55–71) | 56 (45–68) | 63 (55–79) | 60 (49–70)* |
| pH maximum on first day, mmHg | 7.40 (7.30–7.45) | 7.41 (7.35–7.46) | 7.37 (7.23–7.44)* | 7.42 (7.36–7.47) | 7.39 (7.28–7.45)* |
| pH minimum on first day, mmHg | 7.25 (7.11–7.35) | 7.29 (7.19–7.36) | 7.18 (7.05–7.29)* | 7.32 (7.23–7.38) | 7.23 (7.10–7.33)* |
| PaCO2 maximum on first day, mmHg | 45 (37–57) | 44 (36–55) | 46 (37–60) | 45 (37–53) | 45 (36–60) |
| PaCO2 minimum on first day, mmHg | 34 (28–40) | 34 (28–40) | 33 (27–39) | 35 (29–40) | 33 (28–40) |
| PaO2 maximum on first day, mmHg | 144 (98–229) | 135 (94–197) | 149 (101–265) | 141 (95–190) | 145 (99–234) |
| PaO2 minimum on first day, mmHg | 77 (61–98) | 77 (64–94) | 75 (57–105) | 78 (66–90) | 76 (60–100) |
| PaO2/FiO2 maximum on first day | 232 (144–344) | 232 (151–337) | 233 (132–361) | 270 (161–374) | 227 (143–343)* |
| PaO2/FiO2 minimum on first day | 195 (132–288) | 200 (149–294) | 186 (120–285)* | 218 (165–300) | 192 (124–285)* |
| Lactate maximum on first day, mmol/L | 3.6 (2.0–7.6) | 2.6 (1.5–5.5) | 5.8 (2.5–10.5)* | 2.1 (1.2–5.5) | 4.30 (2.3–8)* |
| ICU stay, days | 4 (2–8) | 5 (3–10) | 3 (1–6)* | 4 (2–6) | 4 (1–8) |
| Hospital stay, days | 8 (2–20) | 17 (8–31) | 3 (1–6)* | 15 (8–22) | 5 (2–16)* |
| Limitation of care, | 170 (36) | 40 (16) | 126 (61)* | 11 (11) | 159 (44)* |
| ICU mortality, | 210 (45) | – | 210 (100)* | – | 210 (59) |
| Hospital mortality, | 247 (54) | 37 (15) | 210 (100)* | 11 (11) | 236 (67)* |
Values are given as median (interquartile range) unless otherwise stated
Missing values: 12 for mortality; 5 for sex; 36 for weight; 23 for source of admission; 15 for vasopressors on admission; 15 for ICU stay, 16 for hospital stay
*p < 0.05, survivors versus non-survivors; favorable outcome versus unfavorable outcome
COPD chronic obstructive pulmonary disease, CRRT continuous renal replacement therapy, FiO fraction of inspired oxygen, HIV human immunodeficiency virus, ICU intensive care unit, IHCA in-hospital cardiac arrest, MAP mean arterial pressure, OHCA out-of-hospital cardiac arrest, PaO partial pressure of oxygen, PaCO partial pressure of carbon dioxide, SAPS Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment
Fig. 1Occurrence of extracerebral organ failure on intensive care unit (ICU) admission (upper panel) and during the ICU stay (lower panel) in survivors and non-survivors. *p < 0.05
Fig. 2Time-course of renal-SOFA subscore in survivors and non-survivors (upper panel) and in patients with favorable (FO) and unfavorable neurological outcome (UO) (lower panel). SOFA Sequential Organ Failure Assessment
Fig. 3Occurrence of circulatory, respiratory, and renal failure in patients according to their outcome (alive or dead, with neurological recovery (CNS+) or persistent neurological impairment (CNS–))
Multivariable analysis to identify the independent predictors of ICU mortality and unfavorable outcome
| Variable |
| OR | 95 % CI |
|---|---|---|---|
| Predictors of ICU mortality | |||
| SAPS II score on admission | <0.001 | 1.047 | 1.025–1.069 |
| Lactate max, mEq/L | 0.004 | 1.093 | 1.029–1.161 |
| Renal failure on admission | 0.011 | 2.413 | 1.220–4.774 |
| Severe sepsis during ICU stay | 0.022 | 0.537 | 0.316–0.912 |
| Predictors of unfavorable outcome | |||
| SAPS II on admission | <0.001 | 1.107 | 1.077–1.138 |
| MV on admission | 0.020 | 3.787 | 1.234–11.628 |
| CNS-SOFA on admission | <0.001 | 4.237 | 3.097–5.796 |
CI confidence interval, CNS central nervous system, ICU intensive care unit, Lactate max maximal lactate levels within the first 24 h after ICU admission, MV mechanical ventilation, OR odds ratio, SAPS Simplified Acute Physiological Score, SOFA Sequential Organ Failure Assessment